Journals / Marmara Medical Journal / 2011 / Cilt: 24 - Sayı: 1

Investigation of macrolide resistance mechanisms in streptococcus pneumoniae: Results of Marmara University hospital between 2005-2008

Streptococcus pneumoniae'da makrolid direnç mekanizmalarının Araştırılması: 2005-2008, Marmara Üniversitesi hastanesi sonuçları

Pages
15–20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The demonstration of the mef(A)/(E) gene either alone or together with erm(B) in a high proportion of the isolates (64%) in addition to the high rate of M phenotype (14%) signifies that active macrolide efflux together with the ribosomal target mutation has a significant role in the macrolide resistance of our pneumococcal isolates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to determine the phenotypic characteristics and genetic determinants of macrolide resistance in the clinical isolates of Streptococcus pneumoniae.
📊
Key Findings & Data:Materials and Methods: In 50 erythromycin resistant S. pneumoniae isolates, 14-, 15- membered macrolides and lincosamide susceptibilities were determined by both disk diffusion and broth microdilution methods.
💡
Conclusion & Impact:Conclusion: The demonstration of the mef(A)/(E) gene either alone or together with erm(B) in a high proportion of the isolates (64%) in addition to the high rate of M phenotype (14%) signifies that active macrolide efflux together with the ribosomal target mutation has a significant role in the macrolide resistance of our pneumococcal isolates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to determine the phenotypic characteristics and genetic determinants of macrolide resistance in the clinical isolates of Streptococcus pneumoniae. Materials and Methods: In 50 erythromycin resistant S. pneumoniae isolates, 14-, 15- membered macrolides and lincosamide susceptibilities were determined by both disk diffusion and broth microdilution methods. The erythromycin-clindamycin double disk method was applied for the detection of macrolide resistance phenotypes. Genetic determinants of macrolide resistance, erm(B), erm(TR) and mef(A)/(E) were investigated by Polymerase Chain Reaction (PCR). Results: The percentages of the isolates presenting Macrolide-Lincosamide-Streptogramin B (MLSB) and M phenotypes were 86% (cMLSB phenotype: 76%; iMLSB phenotype: 10%) and 14%, respectively. According to the PCR results, 18 isolates (36%) had erm(B) gene, 11 isolates (22%) had mef(E)/(A) gene and the remaining 21 (%42) isolates had both erm(B) and mef(A)/(E) genes. All erm(B) positive isolates (78%) presented high level macrolide and lincosamide resistance. Seven out of 11 isolates carrying the mef(A)/(E) gene alone presented M phenotype with low level macrolide MICs. Conclusion: The demonstration of the mef(A)/(E) gene either alone or together with erm(B) in a high proportion of the isolates (64%) in addition to the high rate of M phenotype (14%) signifies that active macrolide efflux together with the ribosomal target mutation has a significant role in the macrolide resistance of our pneumococcal isolates.

Özet

Amaç: Bu çalışmada enfeksiyon etkeni olarak izole edilen Streptococcus pneumoniae izolatlarında, makrolid direncinin fenotipik karakteristiklerinin ve genetik determinantlarının belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Eritromisin direnci gösteren 50 S. pneumoniae izolatının 14-, 15- üyeli makrolid ve linkozamid duyarlılıkları disk difüzyon ve sıvı mikrodilüsyon yöntemleriyle saptanmıştır. Makrolid direnç fenotiplerini belirlemek üzere eritromisin-klindamisin çift disk testi kullanılmıştır. Makrolid direncinin genetik determinantları, mef(E)/(A), erm(B) ve erm(TR)’nin saptanmasında Polimeraz Zincir Reaksiyonu (PZR) yöntemi kullanılmıştır. Bulgular: İzolatlarımızın % 86’sı Makrolid-Linkozamid Streptogramin B (MLSB) (%76 cMLSB ve %10 iMLSB), % 14’ü M fenotipi göstermiştir. PZR sonuçlarına göre 18 izolatta (% 36) tek başına erm(B); 11 izolatta (% 22) tek başına mef(E)/(A) geni; geri kalan 21 (% 42) izolatta ise her iki gen birlikte saptanmıştır. erm(B) geni taşıyan tüm izolatlar (%78), yüksek düzey makrolid ve linkozamid direnci gösterirken, mef(E)/(A) genini tek başına taşıyan 11 izolatın 7’si M, 4’ü MLSB fenotipi göstermiştir. M fenotipindeki izolatların makrolid MİK’leri ise düşük düzeyde bulunmuştur. Sonuç: Çalışmamızda mef(A)/(E) geninin tek başına ya da erm(B) ile birlikte izolatların %64’ü tarafından taşındığının gösterilmesi ayrıca M fenotipine sahip izolatların oranının da oldukça yüksek (%14) bulunması, aktif makrolid pompasının, ribozomal hedef mutasyonuyla birlikte hastanemiz pnömokok izolatlarının makrolid direncinde çok önemli rolü olduğunu ortaya koymaktadır.

🔖

Cite This Article

SAĞIROĞLU, P., AKSU, B., HASDEMİR, M. U. (2011). Investigation of macrolide resistance mechanisms in streptococcus pneumoniae: Results of Marmara University hospital between 2005-2008. Marmara Medical Journal, Cilt: 24 - Sayı: 1, 15–20. https://ajindex.com/articles/280992

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Musher, D. M. Streptococcus pneumoniae. In: Mandell GL., Bennett JE., Dolin R., eds. Mandell, Douglass and Bennett' s Principles and Practice of Infectious Diseases. New York: John Wiley & Sons, 2004:2392-2411. doi:10.1086/507699 2. Liñares J, Ardanuy C, Pallares R, Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010
  2. 16(5):402-410. do.:10.1111/j.1469- 0691.2010.03182.x 3. Farrell DJ, Couturier C, Hryniewicz W. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT year 5 (2003–2004). Int J Antimicrob Agents 2008
  3. 245–249. doi:10.1016/j.ijantimicag.2007.10.022 4. The European Antimicrobial Resistance Surveillance System (EARSS) Annual Report 2007 [http://www.rivm.nl/earss/result/Monitoring_repor ts/Annual_reports.Jsp] 5. The European Antimicrobial Resistance Surveillance System (EARSS) Annual Report 2008 [http://www.rivm.nl/earss/result/Monitoring_repor ts/Annual_reports.Jsp]. 6. Varaldo PE, Montanari MP, Giovanetti E. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob Agents Chemother 2009
  4. 53(2):343-353. doi: 10.1128/AAC.00781-08 7. Leclercq R, Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 2002
  5. 46(9): 2727-2734. doi: 10.1128/AAC.46.9.2727-2734.2002 8. Camilli R., Del Grosso M., Iannelli F., Pantosti A. New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae: insertion sites and association with other genetic elements. Antimicrob. Agents Chemother 2008
  6. 619– 625. doi: 10.1128/AAC.01081-07 9. Sener B, Köseoglu O, Gür D, Bryskier A. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey. J Chemother 2005
  7. 17(1):31-35. 10. Gür D, Mülazımoğlu L, Ünal S. In Vitro susceptibility of respiratory isolates of streptococcus pneumoniae and streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e BASKETT II surveillance study. Mikrobiyol Bul 2007
  8. 41(1):1-9. 11. Gülay Z, Özbek ÖA, Biçmen M, Gür D. Macrolide resistance determinants in erythromycin- resistant streptococcus pneumoniae in Turkey. Jpn J Infect Dis 2008
  9. 61, 490-493. 12. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implication